Fatigue stabilizes once your body adjusts to the caloric deficit
Circulation (2013) 127(1):7485
Schaffner, Ph.D.Lisa Mostovoy Tom Taylor-Vigrass Onsera Health Your Weight-Loss Drugs Are Next on the Corporate Chopping Block wsj.com LinkedIn News
Targeting physiology, not just appetite The breakthrough in developing weight loss drugs came through research into GLP-1 (glucagon-like peptide-1) agonists, which were originally developed for treating diabetes
In 1964, the development of insulin radioimmunoassay methods led to the discovery of the incretin effect, which demonstrated that oral glucose intake induces higher insulin secretion compared to intravenous (i.v.) glucose [3,4]
Recently, in addition to the central maintenance of food intake, GLP-1R signaling has begun to be considered in the context of the regulation of the stress response, as it is indicated that it can activate both the hypothalamicpituitaryadrenal (HPA) axis as well as the sympathetic nervous system [15, 16]